Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-010475

Options or other derivatives

  • Director acquired 3,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SCHELLER RICHARD H · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-06-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +3,500 $7.38 2026-06-01 3,500 3,500 D
Loading xslF345X03/form4scheller.xml…